Cargando…
The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients
We encourage studies on the effectiveness of multiple sclerosis drugs for the treatment of ARDS in COVID-19 infection. These drugs, through the inhibition of the RhoA/actin-dependent expression of virus receptors in the macrophages and macrophage recruitment to the lungs, have the potential to inhib...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392845/ https://www.ncbi.nlm.nih.gov/pubmed/32763844 http://dx.doi.org/10.1016/j.msard.2020.102437 |